Federal Agency · Food and Drug Administration
Pathways for Regulatory Innovation and Strategic Modernization (PRISM)
Posted March 31, 2026
Funding
$0 – $1.3M
Closes
April 30, 2026
NAICS
541714
The Pathways for Regulatory Innovation and Strategic Modernization (PRISM) cooperative agreement is intended to advance public health by strengthening the scientific, collaborative, and operational foundations needed to modernize regulatory oversight in an increasingly complex and rapidly evolving public health landscape. As innovation in medical products, diagnostics, foods, and digital health accelerates, our nation must continuously adapt its regulatory science approaches to ensure timely access to safe, effective, and high-quality products for the American public. PRISM is designed to support this modernization by enabling forward-looking, non-regulatory collaborations that align with the Commissioner’s strategic priorities and the Administration’s broader public health goals.
Eligibility
Funded by FDA, Programs related to bridge, Programs related to healthcare, and Programs related to public health.
Award details
Award range: $0 – $1.3M. Applications close on April 30, 2026 (2 days remaining).
Categories
Facility Improvement · Health · Research Innovation
Sign up at GrantRegister to see if this grant matches your organization.
Match my organization →View application on Grants.gov →·Source: Grants.gov·Last seen Apr 28, 2026
